Prevalence of chronic podiatric conditions in the US. National Health Survey 1990

La, Levy

doi:10.7547/87507315-82-4-221

Cited by 30 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Socioeconomic status is another affecting factor in IN. In one previous study, IN was seen more among participants of low SES who earned less than $10 000/year; however, in our study, the IN group showed significantly higher proportions of both low and high SES than did the control group. This could be explained as the fact that persons of lower SES usually engage in physical work that puts heavy loads on their feet and shoes, have poor foot hygiene, and have less access to medical care .…”

Section: Discussioncontrasting

confidence: 96%

“…In our study, incidence and prevalence showed increasing tendencies, and this trend may be influenced by lifestyle changes such as increased participation in physical activities like mountain climbing and golf and by increased health knowledge, promotion of health‐seeking behavior and easily accessible medical facilities. Interestingly, the incidence of IN followed a bimodal distribution with respect to age (~15 and 50 years old), and these findings were similar to those from a previous study . The high prevalence of IN among teenagers can be explained by the association between high physical activity and IN, and the increased IN prevalence in older subjects is associated with its high prevalence in middle‐aged women.…”

Section: Discussionsupporting

confidence: 87%

“…Ingrown nail is a common nail disorder that is frequently encountered by dermatologists. One study in the USA revealed A 2.5–5% prevalence in the general population . In our study, incidence and prevalence showed increasing tendencies, and this trend may be influenced by lifestyle changes such as increased participation in physical activities like mountain climbing and golf and by increased health knowledge, promotion of health‐seeking behavior and easily accessible medical facilities.…”

Section: Discussionsupporting

confidence: 54%

“…Although IN is the most common nail problem, there have been few comprehensive investigations of its prevalence and incidence. The prevalence is known to be as high as 2.5–5%, with male predominance, but there is no study that confirms the prevalence applying recent large data; the etiology of IN is also not well understood. Many risk factors have been suggested to be related to IN pathogenesis, including improper nail trimming, tight‐fitting shoes, hyperhidrosis, bad foot hygiene, abnormal nail shape, trauma, anatomical abnormalities and epidermal growth factor receptor inhibitors such as gefitinib and cetuximab .…”

Section: Introductionmentioning

confidence: 96%

See 3 more Smart Citations

Epidemiology and bone‐related comorbidities of ingrown nail: A nationwide population‐based study

Cho

Kim

Choi

2018

The Journal of Dermatology

View full text Add to dashboard Cite

Although ingrown nail (IN) is common, there is no large‐scale study regarding its epidemiology and risk factors, such as foot deformity. The purpose of this study is to determine the demographics of IN and clarify its association with bone‐related comorbidities of the ankle, foot and toe. Patients in a representative sample cohort of the National Health Information Database of South Korea from 2004 to 2013 who had IN were compared with a control group without IN. Ten‐year overall incidence was 307.5/100 000 person‐years (95% confidence interval, 304.1–310.9). IN incidence and prevalence showed an increasing trend, and IN was more common in women than in men. Incidence showed bimodal peaks, among teenagers and among participants in their 50s. The IN group showed more common valgus deformity (64.3%) than did the control group (61.6%), and flat foot was also a significant risk factor of IN. There were increasing tendencies of IN incidence and prevalence among females. Confirmed bone deformity, especially acquired valgus or varus deformity, and flat foot were associated with IN.

show abstract

Section: Discussioncontrasting

confidence: 96%

Section: Discussionsupporting

confidence: 87%

Section: Discussionsupporting

confidence: 54%

Section: Introductionmentioning

confidence: 96%

See 2 more Smart Citations

Epidemiology and bone‐related comorbidities of ingrown nail: A nationwide population‐based study

Cho

Kim

Choi

2018

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…83.6% in all groups) and white (50.7% in the oxycodone HCl IR 10-mg group to 73.1% in the placebo group). The higher proportion of female patients is consistent with previously published demographic data for bunionectomy surgery 16,17 . At baseline, most patients described their pain as moderate with the VRS and their mean pain intensity ranged from 6.0 to 6.5 using the NRS.…”

Section: Patientssupporting

confidence: 91%

The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery

Stegmann

Weber

Steup

et al. 2008

Current Medical Research and Opinion

View full text Add to dashboard Cite

C o p y r i g h t I n f o r m a U K L i m i t e d 2 0 0 8 N o t f o r S a l e o r C o m e r c i a l D i s t r i b u t i o n U n a u t h o r i z e d u s e p r o h i b i t e d . A u t h o r i s e d u s e r s c a n d o w n l o a d , A B S T R A C TObjective: Tapentadol is a new, centrally acting analgesic with two mechanisms of action, combining m-opioid agonism and norepinephrine reuptake inhibition in a single molecule. This study assessed tapentadol immediate release (IR) in patients with postsurgical orthopedic pain.Methods: This randomized, double-blind, phase II study involved patients with moderate-to-severe pain after bunionectomy surgery (first metatarsal with osteotomy). Patients (N ¼ 269) were randomly assigned to receive tapentadol IR 50 or 100 mg, oxycodone HCl IR 10 mg, or placebo; the study drug was taken every 4-6 h, over a 72-h period starting 1 day after surgery (Evaluation Day 2). The primary endpoint was the sum of pain intensity over 24 h (SPI-24) on the second day after randomization (Evaluation Day 3). Potential limitations of this study included the use of rescue medication and the fact that it was not powered to statistically compare between-group differences in tolerability measures. Results: Mean (standard deviation [SD]) SPI-24 values on Evaluation Day 3 were significantly lower for tapentadol IR (50 mg: 33.6 [19.7], p ¼ 0.0133; 100 mg: 29.2 [15.2], p ¼ 0.0001) and oxycodone HCl IR 10 mg (35.7 [17.2]; nominal p ¼ 0.0365) compared with placebo (41.9 [17.7]). The most common treatment-emergent adverse events for all treatment groups were characteristic of drugs with m-opioid agonist activity. While providing similar analgesic efficacy, tapentadol IR 50 mg was associated with lower rates of nausea (46.3% vs. 71.6% for oxycodone HCl IR 10 mg), dizziness (32.8% vs. 56.7%), vomiting (16.4% vs. 38.8%), and constipation (6.0% vs. 17.9%), and a similar rate of somnolence (28.4% vs. 26.9%) compared with oxycodone HCl IR 10 mg.Conclusions: Tapentadol IR 50 and 100 mg and oxycodone HCl IR 10 mg were effective in this study for the relief of acute postoperative pain following bunionectomy. The study results suggest improved gastrointestinal tolerability of tapentadol IR 50 mg compared with oxycodone at a dose showing comparable efficacy.

show abstract

Unguis incarnatus – konservative oder operative Therapie? Ein praktischer Behandlungsalgorithmus

et al. 2020

View full text Add to dashboard Cite

Zusammenfassung Der Unguis incarnatus ist ein häufiges Krankheitsbild, mit dem sich Patienten in der Hausarztpraxis, der dermatologischen Klinik oder der chirurgischen Notaufnahme vorstellen. Häufig führt die inkonsequente konservative Therapie oder die falsch-indizierte operative Intervention zu langwierigen und komplikationsreichen Verläufen, inklusive Rezidiven. Die Patienten sollten über die Komplexität des Nagelorgans aufgeklärt werden, um der Banalisierung der Erkrankung vorzubeugen, und eine entsprechende Compliance in der Therapie zu erreichen. In diesem Manuskript wird die sachgerechte Versorgung des Unguis incarnatus im Sinne eines praktischen Behandlungsalgorithmus dargestellt. Die konsequente konservative Therapie ist bei akutem Unguis incarnatus mit milder Ausprägung die Therapie der ersten Wahl mit guten Behandlungsergebnissen. Nagelerhaltende operative Eingriffe kommen bei moderaten/schweren akuten Formen zum Einsatz. Der chronische Unguis incarnatus, ohne floride Infektion, stellt eine elektive Operationsindikation dar. Sowohl bei den nagelerhaltenden Eingriffen als auch bei erweiterten operativen Maßnahmen ist eine chirurgische Operationsaufklärung obligat.

show abstract

Prevalence of chronic podiatric conditions in the US. National Health Survey 1990

Cited by 30 publications

References 0 publications

Epidemiology and bone‐related comorbidities of ingrown nail: A nationwide population‐based study

Epidemiology and bone‐related comorbidities of ingrown nail: A nationwide population‐based study

The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery

Unguis incarnatus – konservative oder operative Therapie? Ein praktischer Behandlungsalgorithmus

Contact Info

Product

Resources

About